Home › Funds › Fairmount Funds Management LLC › ELVN
Fairmount Funds Management LLC position in ELVN
ENLIVEN THERAPEUTICS INC · Health Care
Fairmount Funds Management LLC reported holding 1,855,644 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$85.1M, representing 5.33% of its reported portfolio and ranking #7 among its reported holdings. Fairmount Funds Management LLC has disclosed ELVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Fairmount Funds Management LLC's ELVN position evolved
Fairmount Funds Management LLC first disclosed a stake in ELVN in Q3 2023 at 2,131,369 shares (US$29.1M). The position peaked in Q2 2026 at 1,855,644 shares, worth US$94.2M. Across 13 filings, Fairmount Funds Management LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 1,855,644 shares valued at US$85.1M. Notable position changes include a 50% increase in Q1 2024 (shares rose 33% over the following quarter), a 50% trim in Q1 2026 (shares rose 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.13M | $29.11M | New |
| Q4 2023 | 2.13M | $29.50M | Hold |
| Q1 2024 | 3.20M | $56.34M | Add |
| Q2 2024 | 3.20M | $74.85M | Hold |
| Q3 2024 | 3.20M | $81.80M | Hold |
| Q4 2024 | 3.20M | $72.06M | Hold |
| Q1 2025 | 3.20M | $63.03M | Hold |
| Q2 2025 | 3.71M | $74.45M | Add |
| Q3 2025 | 3.71M | $75.97M | Hold |
| Q4 2025 | 3.71M | $57.16M | Hold |
| Q1 2026 | 1.86M | $72.74M | Reduce |
| Q2 2026 | 1.86M | $94.17M | Hold |
| Q3 2026 | 1.86M | $85.06M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELVN and 13F data
ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$310.6M), Polar Capital Holdings Plc (US$294.5M), Commodore Capital LP (US$150.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELVN
- ORBIMED ADVISORS LLC 6.78M sh · $310.64M · Q3 2026
- Polar Capital Holdings Plc 6.43M sh · $294.53M · Q3 2026
- Commodore Capital LP 3.27M sh · $150.13M · Q3 2026
- Vestal Point Capital, LP 3.23M sh · $147.83M · Q3 2026
- Siren, L.L.C. 1.48M sh · $67.62M · Q3 2026
- Bellevue Group AG 1.47M sh · $67.34M · Q3 2026
- Logos Global Management LP 1.08M sh · $49.51M · Q3 2026
- First Light Asset Management, LLC 1.02M sh · $46.68M · Q3 2026
- Novo Holdings A/S 1.00M sh · $45.84M · Q3 2026
- First Turn Management, LLC 958.70K sh · $43.95M · Q3 2026
- SAMLYN CAPITAL, LLC 936.17K sh · $42.91M · Q3 2026
- BAKER BROS. ADVISORS LP 905.19K sh · $41.49M · Q3 2026
More on Fairmount Funds Management LLC
FAQ
How long has Fairmount Funds Management LLC held ELVN?
Fairmount Funds Management LLC has disclosed ELVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Fairmount Funds Management LLC's current position in ELVN?
As of Q3 2026, Fairmount Funds Management LLC holds 1.86M shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $85.06M, representing 5.33% of its reported portfolio and ranking #7.
Has Fairmount Funds Management LLC been buying or selling ELVN?
In the latest 13F filing (Q3 2026), Fairmount Funds Management LLC held unchanged its position in ELVN. The position peaked in Q2 2026 at 1.86M shares.
Which other funds hold ELVN?
Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Commodore Capital LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.